12/01/2019 03:50:00

ALLERGAN SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Allergan plc. - AGN

NEW ORLEANS, Jan. 11, 2019 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 19, 2019 to file lead plaintiff applications in a securities class action lawsuit against Allergan plc. (NYSE: AGN), if they purchased the Company’s shares between February 24, 2017, and December 19, 2018, inclusive (the “Class Period”).  This action is pending in the United States District Court for the Southern District of New York.

Get Help

Allergan investors should visit us at https://www.claimsfiler.com/cases/view-allergan-plc-securities-litigation-1 or call toll-free (844) 367-9658.  Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.

About the Lawsuit

Allergan and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws. 

On December 19, 2018, the Company announced that it had halted the sale of its textured breast implants in the European market following a compulsory recall request from the French regulatory authority, Agence Nationale de Sécurité du Médicament, after the product’s CE Mark certification expired, amid concerns of a link to a rare form of cancer.

On this news, the price of Allergan’s shares plummeted.

The case is Cook v. Allergan Plc et al, No. 18-cv-12089.

About ClaimsFiler

ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. At ClaimsFiler.com, investors can: (1) register for free to gain access to information and settlement websites for various securities class action cases so they can timely submit their own claims; (2) upload their portfolio transactional data to be notified about relevant securities cases in which they may have a financial interest; and (3) submit inquiries to the Kahn Swick & Foti, LLC law firm for free case evaluations.

To learn more about ClaimsFiler, visit www.claimsfiler.com.

Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
21 Jul
GEN
Hmm. Det er med blandede følelser jeg for tid til anden følger med i Genmab trådende. Da Genmab s b..
16
17 Jul
I:SP500
På verdensplan vil næsten ingen acceptere økonomisk tilbageholdenhed til fordel for klimaet. En mill..
16
18 Jul
 
Foranlediget lidt af debatten i den sidste uges tid, kommer her fredagsjoken: En investor her på EI..
15
20 Jul
TEVA
Henningmaria: Casen omkring Teva har ikke ændret sig fundamentalt blot folks følelser pga verserende..
13
17 Jul
I:SP500
Tøjindustrien står for 10 % af udslippet af klimagasser ifølge The Angry Clean Energy Guy. Det er me..
13
17 Jul
 
Jeg er kvinde på 75 år og har haft afdragsfrit lån i 10 år. Min tidligere bankrådgiver, som vdste mi..
12
16 Jul
VELO
At der er nogle som hiver lidt gevinst hjem. Fred være med det. Velo skal op i en helt anden kurs, n..
12
15 Jul
BAVA
Tænk engang, med alt det du skriver om Bavarian og ebola vaccinen, så skulle man tro, at du bare ved..
12
18 Jul
VELO
Jeg havde ligeledes håbet der var mulighed for at supplere lidt længere nede, men nu hedder det nok ..
11
15 Jul
VELO
At optimisme er et advarselstegn er da hul i hovedet. Det kommer an på hvad optimismen bunder i. For..
11

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
22 July 2019 02:52:24
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190703.1 - EUROWEB4 - 2019-07-22 03:52:24 - 2019-07-22 02:52:24 - 1000 - Website: OKAY